Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Sulfo-NHS-LC-Biotin: Practical Labeling Guide
2026-09-18
Sulfo-NHS-LC-Biotin is a water-compatible reagent for permanent biotinylation of accessible primary amines on proteins, peptides, and intact cell surfaces. It is suited to streptavidin-based detection or capture, but not to reversible labeling or routine intracellular biotinylation because it is membrane-impermeable and forms irreversible amide bonds.
-
Peptidisc-Assisted Nanobody Polybody Engineering
2026-09-18
Chen and Duong van Hoa describe a peptidisc-assisted hydrophobic clustering strategy that assembles nanobodies into soluble multimeric, bispecific, and autofluorescent polybodies. The approach uses a transmembrane segment to drive association and a peptidisc membrane mimetic to stabilize the resulting complexes, increasing apparent target binding through avidity while expanding nanobody engineering options.
-
OSMI-1 for Reproducible OGT Inhibition Assays
2026-09-17
This scenario-based guide explains how OSMI-1 (SKU B7923) can support controlled O-GlcNAc transferase inhibition, viability testing, and mechanistic interpretation. It covers dosing, DMSO compatibility, target-engagement controls, safety, and practical supplier-selection criteria.
-
Proteinase K as a Sample-Logic Enzyme
2026-09-17
Proteinase K is more than a genomic DNA isolation enzyme: its biochemical resilience can help researchers design cleaner, more interpretable sample-processing workflows. This article connects controlled protein hydrolysis with findings from a Candida albicans extracellular-vesicle study while defining practical limits and assay decisions.
-
Dabigatran A4077: Reliable Thrombin Assays
2026-09-16
This scenario-based guide explains how Dabigatran, SKU A4077, can improve experimental control in thrombin inhibition and coagulation studies while avoiding common formulation and interpretation errors. It also clarifies the limits of extending coagulation findings into cell viability or cytotoxicity assays.
-
Shrimp STING Reveals an Ancestral DNA-Sensing Axis
2026-09-16
The reference study demonstrates that shrimp STING can recognize both cytosolic double-stranded DNA and cyclic dinucleotides, linking nucleic-acid detection to an IFN-like antiviral program. Its identification of a dsDNA–STING–IKKε–IRF–Vago4 axis expands current models of innate immune evolution and provides a framework for studying antiviral signaling in arthropods.
-
Reversible Surface Proteomics with Sulfo-NHS-SS-Biotin
2026-09-15
A mechanistic and translational guide to using Sulfo-NHS-SS-Biotin for reversible cell-surface labeling, affinity purification, and orthogonal validation of spatial protein interactions, with Notch receptor trafficking as a strategic case study.
-
Biotin (Vitamin B7) for Protein and Motor Assays
2026-09-15
A practical guide to using Biotin (Vitamin B7) across metabolic experiments, avidin-based detection, and protein-labeling controls. It also translates recent BicD–MAP7–kinesin findings into assay designs while separating true motor activation from biotin-enabled immobilization artifacts.
-
BAPTA-AM in Calcium-Dependent NMJ Assays
2026-09-14
BAPTA-AM is a cell-permeable calcium chelator for testing how intracellular Ca²⁺ controls localized BDNF release and neuromuscular junction assembly. This article translates recent NMJ findings into rigorous assay design while addressing optical, electrophysiological, and cytotoxicity-related confounders.
-
Sulfo-NHS-LC-Biotin Protocol Guide
2026-09-14
Sulfo-NHS-LC-Biotin provides a water-soluble method for covalently labeling accessible primary amines on proteins, peptides, and intact-cell surfaces. It is suited to permanent biotin capture and detection workflows, but not to reversible labeling or intracellular labeling of cells with an intact plasma membrane.
-
MiR-24-3p in Doxorubicin-Induced Heart Failure
2026-09-13
The reference study identifies a miR-24-3p/Sp1/PI3K regulatory axis that links doxorubicin-induced cardiomyocyte injury with apoptosis, oxidative stress, and impaired cardiac function. Its combined rat, cell, inhibitor, genetic-manipulation, and reporter-assay design provides a mechanistic framework for evaluating miR-24-3p silencing as a potential heart-failure strategy, while still requiring validation beyond experimental models.
-
Endogenous Melatonin, IRF3, and M1-Like Macrophages
2026-09-12
A 2024 Experimental Cell Research study shows that LPS stimulates macrophage melatonin production through the TLR4/TRIF/IRF3 axis and activates Aanat transcription. The findings position endogenous melatonin as a feedback mechanism that limits M1-like polarization, oxidative stress, and apoptosis during inflammatory activation.
-
LY2228820: Translational Control of p38 MAPK
2026-09-11
A mechanistic and strategic guide to using LY2228820, a selective p38 MAP kinase inhibitor, for target-engagement studies, anti-inflammatory research, cancer research, apoptosis assays, and multiomics-enabled translational decisions.
-
Metoprolol Research Workflows for Translational Assays
2026-09-11
Build reproducible beta1-receptor, cardiovascular, inflammation, and exploratory oncology assays with Metoprolol. This workflow connects concentration-response design and fresh-solution handling with pharmacokinetic lessons from tissue-distribution research.
-
How Kinase Inhibitors Tune p38α Dephosphorylation
2026-09-10
The reference study shows that selected kinase inhibitors can do more than occupy the p38α active site: they can reshape its activation loop to accelerate dephosphorylation by WIP1. This conformational mechanism offers a framework for designing inhibitors that combine direct kinase blockade with phosphatase-facilitated pathway shutdown.